KG
Therapeutic Areas
Zymeworks Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ziihera® (zanidatamab) | Biliary tract cancers, HER2+ solid tumors | Approved |
| Pasritamig | Gastrointestinal stromal tumor (GIST) | Phase 2/3 |
| ZW191 | Ovarian cancer, Endometrial cancer, Non-small cell lung cancer | Phase 1 |
| ZW251 | Hepatocellular carcinoma (HCC) | Phase 1 |
| ZW220 | Ovarian cancer, NSCLC, Pancreatic cancer | Preclinical |
| ZW209 | DLL3-expressing cancers | Preclinical |
| ZW1528 | Mixed-type COPD | Preclinical |